Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Birth outcomes after exposure to mebendazole and pyrvinium during pregnancy - A Danish nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prospective multi-centre randomised trial comparing induction of labour with a double-balloon catheter versus dinoprostone

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Expectant management of PPROM and major complications before planned delivery: A retrospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Osteomyelitis of the pubic symphysis - A case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Risk of a venous thromboembolic episode due to caesarean section and BMI: A study in northern Denmark covering 2000-2010

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Mebendazole and pyrvinium are anthelmintics used to treat infections with pinworms, a common infection in children. Other indications for treatment with mebendazole are infections with soil-transmitted helminths. These infections are rare in Denmark, but affect more than 1.5 billion people worldwide. Limited safety data of anthelmintics during pregnancy exists and the purpose of this study was to investigate the association between exposure to mebendazole or pyrvinium during pregnancy and the adverse pregnancy outcomes: congenital malformations, stillbirths, neonatal mortality and small for gestational age. The Danish Fertility Database was used to identify all births in Denmark from 1997 to 2007. Maternal exposure to anthelmintics was identified through The Danish Prescription Registry. Of 713667 births, 2567 mothers redeemed a prescription for mebendazole; 1588 for pyrvinium. Logistic regression analysis adjusted for potential confounders. We found no association between exposure to mebendazole and major congenital malformations (OR = 0.7 (CI 95% 0.5-1.1)) or other negative birth outcomes and we found no association between exposure to pyrvinium and major congenital malformations (OR = 0.8 (CI 95% 0.4-1.5)) or other negative birth outcomes. No increased risk was found of having negative birth outcomes after exposure at any trimester during pregnancy.

OriginalsprogEngelsk
TidsskriftJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Vol/bind38
Udgave nummer8
Sider (fra-til)1020-1025
Antal sider6
ISSN1090-1213
DOI
StatusUdgivet - nov. 2016

ID: 46471593